Article info
PDFOriginal Article
Issues of consent and feedback in a genetic epidemiological study of women with breast cancer
- Correspondence to: M Richards, Centre for Family Research, University of Cambridge, Free School Lane, Cambridge CB2 3RF; mpmr{at}cam.ac.uk
Citation
Issues of consent and feedback in a genetic epidemiological study of women with breast cancer
Publication history
- Accepted July 2, 2002
- Revised June 25, 2002
- First published April 1, 2003.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 by the Journal of Medical Ethics
Other content recommended for you
- Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
- Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
- BRCA1 andBRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
- Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
- Unique de novo mutation of BRCA2 in a woman with early onset breast cancer
- Breast cancer susceptibility variants alter risks in familial disease
- Retesting of women who are negative for a BRCA1 and BRCA2 mutation using a 20-gene panel
- Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries
- Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening
- Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women